Sapphiros Acquires Flexotronix Limited
09/08/22, 9:43 PM
Location
boston
Industry
biotechnology
manufacturing
Sapphiros has today completed the acquisition of Flexotronix Limited. Flexotronix have developed a high speed printed electronics manufacturing line using in-house proprietary conductive inks and printed components, including batteries connectivity capability- and other diagnostic test control mechanisms. These technologies will be rapidly deployed across the Sapphiros portfolio of companies to dramatically lower consumable costs and ultimately fully automate diagnostic testing and data management for products such as the SatioDx blood draw patches and next generation Biocrucible molecular diagnostics rapid diagnostic test devices.
Company Info
Location
Boston, Massachusetts, United States
Company info
Sapphiros, backed by Neoenta and KKR, is a privately held consumer diagnostic portfolio company. The Sapphiros portfolio includes novel sample collection, next generation diagnostics, computational biology, and printed electronics to help consumers access important diagnostic results globally. Knowing Now Moves Us™
Knowledge empowers us to navigate through life’s choices and decisions. With solutions that provide real-time, definitive results; at Sapphiros we work together to help global communities act on these insights with confidence.